Hoover's coverage by Rachel Meyer -- What Responsible Corporate Citizen Are You?

[ Show ]

Support VoyForums

[ Shrink ]

VoyForums Announcement: Programming and providing support for this service has been a labor of love since 1997. We are one of the few services online who values our users' privacy, and have never sold your information. We have even fought hard to defend your privacy in legal cases; however, we've done it with almost no financial support -- paying out of pocket to continue providing the service. Due to the issues imposed on us by advertisers, we also stopped hosting most ads on the forums many years ago. We hope you appreciate our efforts.

Show your support by donating any amount. (Note: We are still technically a for-profit company, so your contribution is not tax-deductible.) PayPal Acct: Feedback:

Donate to VoyForums (PayPal):

[ Login ] [ Contact Forum Admin ] [ Main index ] [ Post a new message ] [ Search | Check update time | Archives: 1, 2, 3, [4], 5 ]

[ Next Thread | Previous Thread | Next Message | Previous Message ]

Date Posted: 06:06:09 08/04/06 Fri
Author: Daiichi Pharmaceutical Co., Ltd.
Subject: Hoover's coverage by Rachel Meyer
In reply to: Mr. Iwaya �C May 29, 2002 's message, "Transcription of Pharmaceutical Market in Japan" on 06:02:47 08/04/06 Fri

Daiichi Pharmaceutical Co., Ltd. Sponsored by: 14-10, Nihonbashi 3-chome, Chuo-ku
Tokyo, 103-8234, JapanPhone: +81-3-3272-0611
Fax: +81-3-3272-7348
http://www.daiichipharm.co.jp

Hoover's coverage by Rachel Meyer

Tools from our advertising partners:
Build A Report Print This Page E-Mail
Overview
Daiichi Pharmaceutical makes prescription drugs, OTC treatments, and animal health products. The firm's prescription drugs include treatments for allergies, hypertension, and stroke; it also has several drugs in clinical trials. OTC medications include cold remedies and pain relievers. Its fine chemicals division makes bulk products for pharmaceuticals, food additives, and other uses. The firm has tried to boost research and development through research alliances with companies such as Sanofi-Aventis. Daiichi now operates as a wholly owned subsidiary of Daiichi Sankyo, after having been acquired by Sankyo Co. for $7.7 billion in 2005.

Sample Overview
Key Numbers
Key financials for Daiichi Pharmaceutical Co., Ltd.

Many investment options: no-fee IRAs, low-cost CDs, bonds & mutual funds. Company Type Subsidiary of Daiichi Sankyo
Fiscal Year-End March
2005 Sales (mil.) $3,054.7
1-Year Sales Growth (0.0%)
2005 Net Income (mil.) $345.7
1-Year Net Income Growth 37.0%
2005 Employees 7,333
1-Year Employee Growth (0.6%)

Get more Key Numbers
TIP: Want to stay abreast of the latest in IPO news? Sign up for Hoover's IPO Update newsletter and start receiving exclusive Hoover's content delivered straight to your inbox. Each newsletter is delivered weekly to help you stay ahead of the competition.
Key People
Key people and executives for Daiichi Pharmaceutical Co., Ltd.

President and CEO Kiyoshi Morita
(Subscribers see complete biographies -- view sample)
Sample more Key People
TIP: Use Build Executive List to target decision makers by industry, geography, sales, net income, and number of employees.
Top Competitors
Top competitors of Daiichi Pharmaceutical Co., Ltd.

Kyowa Hakko Kogyo
Sankyo Co
Takeda Pharmaceutical
There are 14 competitors for Daiichi Pharmaceutical; see more.
TIP: Analyze the Competitive Landscape to view a head-to-head comparison of a firm's profitability, operations, growth, and valuation versus that of its top three competitors.
Industry Information
Primary and secondary industries for Daiichi Pharmaceutical Co., Ltd.

Pharmaceuticals
Pharmaceuticals Manufacturers (primary)
Diagnostic Substances
Over-the-Counter Medications
Vitamins, Nutritionals & Other Health-Related Products
TIP: See what companies are creating the biggest impact each week with Hoover's Hottest Companies newsletter. Sign up now and start receiving exclusive Hoover's content delivered straight to your inbox. Each newsletter is delivered weekly to help you stay ahead of the competition.Industry WatchSponsored by BP
Industry analysis videos for the industries of Daiichi Pharmaceutical Co., Ltd.

Miller Tabak Pharmaceuticals Analyst Les Funtleyder (2:41)
07/27/06 8:05ET - Funtleyder discusses Bristol-Meyers' earnings.
View more industry interviews Hoover's Hottest Companies

Sponsored by BMO

Sign up to receive it in your inbox
For one week each month Hoover's Hottest Companies will bring you The Hoover's 100, a monthly list of companies most searched by our subscribers.

Keep Informed With Hoover's Free Newsletters
Visit the E-mail Newsletter Preference Center to Subscribe Today!
Trading Toolbox Trade Here
Related Products From Our Trusted PartnersBuy Reports and Books
Daiichi Pharmaceutical Co., LTD: Company Profile

(Datamonitor, Feb 1, 2006, Business Reports)
Diagnostic Substances: Financial Analysis Profiles

(BizMiner, Jun 1, 2006, Business Reports)
The U.S. Blood Pressure Monitoring Equipment Markets

(Frost & Sullivan, May 30, 2003, Business Reports)
The Pharmaceutical Pricing and Reimbursement Systems of Central and Eastern Europe

(Urch Publishing, Jun 24, 2002, Business Reports)
ValuEngine Quantitative Industry Report for DRUGS

(ValuEngine, Inc., Nov 1, 2002, Business Reports)
Anti-Aging Products to 2007 (Study # 1682)

(Freedonia Group, Inc., Jul 1, 2003, Business Reports)
PharmaVitae 2002: Daiichi Pharmaceutical

(Datamonitor, Nov 28, 2002, Business Reports)
Diagnostic Substances: Marketing Research Profiles

(BizMiner, Jun 1, 2006, Business Reports)
More Reports and Books

Report Search

Additional 3rd Party Libraries Sponsored LinksSearch Hoover'sby Name / Ticker Executive Name Industry Keyword News/Press Releases Reports Browse Industries View Free ContentFact Sheet NewsNews Stories Press Releases
Industry Watch FinancialsIncome Statement Balance Sheet Cash Flow Sample Subscriber ContentOverview & History Key People Executive Biographies Competitors Products/Operations Historical Financials Company Watch List Downloadable Financials Family Tree Viewer Get more info on Daiichi Pharmaceutical with a D&B Report.
Additional LinksWork More Efficiently
Personal Finance Center
The Hoover's 100
The Leadership 100
High Tech Traveler
Sales Performance Center
Small Business Center
CEOs On Camera
Industry Watch
Firefox Search Plugin
Hoover's Books
Sign Up For Newsletters
Check Out Hot IPOs
View A Webinar
Advanced Report Search
Sales Performance Center
Hoover's and Miller Heiman have joined forces to bring you the the Sales Performance Center.

Take The Tour Subscription Options About Hoover's Books Advertise Help Feedback Site Map Choose Your Edition
Privacy Policy Copyright �0�8 2006, Hoover's, Inc., All Rights Reserved
Website - http://www.hoovers.com/daiichi-pharmaceutical/--ID__59671--/free-co-factsheet.xhtml

[ Next Thread | Previous Thread | Next Message | Previous Message ]

Replies:

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS -- UNITED STATES OF AMERICA v. DAIICHI PHARMACEUTICAL CO., LTD, 06:18:49 08/04/06 Fri
- More than $850 Million in Criminal Fines Obtained in Vitamins Investigation, To Date -- Department of Justice, 06:22:22 08/04/06 Fri
- 3 JAPANESE COMPANIES AGREE TO PLEAD GUILTY, PAY CRIMINAL FINES, FOR PARTICIPATING IN INTERNATIONAL -- Department of Justice, 06:27:05 08/04/06 Fri
  - ARCHER DANIELS MIDLAND CO. TO PLEAD GUILTY AND PAY $100 MILLION FOR ROLE IN TWO INTERNATIONAL PRICE- -- Largest Criminal Antitrust Fine Ever, 06:29:57 08/04/06 Fri
- Guidelines of Action for Compliance -- Corporate Conduct Guidelines, 06:48:51 08/04/06 Fri
  - United States v. Daiichi Pharmaceutical Co., Ltd. -- Antitrust Case Filings, 21:42:06 08/04/06 Fri
  - United States v. Daiichi Pharmaceutical Co., Ltd. -- Antitrust Division, 21:43:40 08/04/06 Fri
- UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS -- Criminal No.: 96-CR-00640, 17:50:04 08/04/06 Fri
  - (N. D. Tex. 1999) (Japanese firm; defendant agreed to $25 million fine in plea agreement) -- United States v. Daiichi Pharmaceutical Co., Ltd., 21:03:02 08/04/06 Fri
    - Guidelines of Action for Compliance -- Corporate Conduct Guidelines, 21:10:37 08/04/06 Fri
      - Daiichi Wins Lawsuit Against Mylan Pharmaceuticals Regarding Patents for Levofloxacin -- Aki Tsukioka, 21:16:12 08/04/06 Fri
        Sankyo, Daiichi Pharmaceutical to Establish Joint Healthcare Business Company -- JCN Staff Writer, 21:19:05 08/04/06 Fri
Defective Drugs: Floxin: liver failure and death -- Sheller, Ludwig & Sheller, 06:34:12 08/04/06 Fri
- Welcome to the Quinolone Antibiotics Adverse Reaction Forum -- For discussing adverse reactions to Quinolone antibiotics, 06:37:13 08/04/06 Fri
  - The Fluoroquinolone Toxicity Research Foundation -- Kristen Pettijohn RIP, 06:39:09 08/04/06 Fri
    - Welcome To The Fluoroquinolone Toxicity Research Foundation -- Unsafe At Any Dose, 06:41:49 08/04/06 Fri
      - YOU MUST NEVER TAKE ANOTHER FQ ANTIBIOTIC AGAIN. -- FQ Victims, 06:43:48 08/04/06 Fri
        Buy cheap Levaquin - Levofloxacin without prescriptions needed -- Levaquin (Levofloxacin), 18:17:10 08/04/06 Fri
        Buy Cheap Levaquin Online -- Levaquin (Levofloxacin), 18:21:38 08/04/06 Fri
        Bitter Pills - Inside the Hazardous World of Legal Drugs -- STEPHEN FRIED, 18:54:04 08/04/06 Fri
Daiichi Sankyo. Two traditions. One Vision. Adding to the Balance of Life. -- Daiichi Sankyo, 18:39:36 08/04/06 Fri
- We, Daiichi Sankyo Group, as "Global Pharmaceutical Innovator", -- Daiichi Sankyo, 18:44:16 08/04/06 Fri
  - Policies Pertaining to the Protection of Personal Information -- Protection of Personal Information, 18:45:55 08/04/06 Fri
Daiichi Pharmaceutical Company Pharmaceutical Plant, Beijing, China -- The Website for the Pharmaceutical Industry, 21:25:57 08/04/06 Fri

[ Contact Forum Admin ]

Forum timezone: GMT-8
VF Version: 3.00b, ConfDB:
Before posting please read our privacy policy.
VoyForums^(tm) is a Free Service from Voyager Info-Systems.
Copyright © 1998-2019 Voyager Info-Systems. All Rights Reserved.